UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 210

Sortiert nach

Development and evaluation of a sublingual tablet based on recombinant Bet v 1 in birch pollen‐allergic patients

Allergy (Copenhagen), 2015-07, Vol.70 (7), p.795-804

2015

Link zum Volltext

Verfügbarkeit prüfen

Allergen Immunotherapy (AIT): a prototype of Precision Medicine

The World Allergy Organization journal, 2015-11, Vol.8 (1), p.31-10, Article 31

2015

Link zum Volltext

Verfügbarkeit prüfen

The average Adjusted Symptom Score, a new primary efficacy end-point for specific allergen immunotherapy trials

Clinical and experimental allergy, 2011-09, Vol.41 (9), p.1282-1288

2011

Link zum Volltext

Verfügbarkeit prüfen

House dust mite sublingual immunotherapy is safe in patients with mild‐to‐moderate, persistent asthma: a clinical trial

Allergy (Copenhagen), 2016-02, Vol.71 (2), p.249-257

2016

Link zum Volltext

Verfügbarkeit prüfen

House dust mite sublingual immunotherapy is safe and appears to be effective in moderate, persistent asthma

Allergy (Copenhagen), 2014-09, Vol.69 (9), p.1181-1188

2014

Link zum Volltext

Verfügbarkeit prüfen

In allergic rhinitis, work, classroom and activity impairments are weakly related to other outcome measures

Clinical and experimental allergy, 2016-11, Vol.46 (11), p.1456-1464

2016

Link zum Volltext

Verfügbarkeit prüfen

Absence of IgE neosensitization in house dust mite allergic patients following sublingual immunotherapy

Clinical and experimental allergy, 2012-10, Vol.42 (10), p.1510-1518

2012

Link zum Volltext

Verfügbarkeit prüfen

The minimally important difference in the Rhinoconjunctivitis Total Symptom Score in grass‐pollen‐induced allergic rhinoconjunctivitis

Allergy (Copenhagen), 2014-12, Vol.69 (12), p.1689-1695

2014

Link zum Volltext

Verfügbarkeit prüfen

Comments on: "allergen immunotherapy as a drug: the new deal of grass allergen tablets from clinical trials to current practice"

European annals of allergy and clinical immunology, 2014-05, Vol.46 (3), p.125

2014

Link zum Volltext

Verfügbarkeit prüfen

Allergen-specific CD4+ T cell responses in peripheral blood do not predict the early onset of clinical efficacy during grass pollen sublingual immunotherapy

Clinical and experimental allergy, 2012-12, Vol.42 (12), p.1745-1755

2012

Link zum Volltext

Verfügbarkeit prüfen

Changes in basophil activation during grass‐pollen sublingual immunotherapy do not correlate with clinical efficacy

Allergy (Copenhagen), 2011-12, Vol.66 (12), p.1530-1537

2011

Link zum Volltext

Verfügbarkeit prüfen

Post-treatment, Long-term Clinical Efficacy Of A 300 IR Sublingual Tablet of 5-grass Pollen Allergen Extract In Adults With Grass Pollen-induced Allergic Rhinoconjunctivitis

Journal of allergy and clinical immunology, 2012-02, Vol.129 (2), p.AB144-AB144

2012

Link zum Volltext

Verfügbarkeit prüfen

Sustained Efficacy and Safety Of a Pre-coseasonal 300IR 5-grass Pollen SLIT Tablet Over 3 Pollen Seasons In Adult SAR

Journal of allergy and clinical immunology, 2011-02, Vol.127 (2), p.AB151-AB151

2011

Link zum Volltext

Verfügbarkeit prüfen

Consistency Of Clinical Results Throughout Short-term And Long-term Studies With Sublingual 300IR 5-grass Pollen Tablets

Journal of allergy and clinical immunology, 2011-02, Vol.127 (2), p.AB49-AB49

2011

Link zum Volltext

Verfügbarkeit prüfen

Post-treatment Efficacy Of House Dust Mites (HDM) Sublingual Immunotherapy (SLIT) Tablets In Adult Patients

Journal of allergy and clinical immunology, 2011-02, Vol.127 (2), p.AB74-AB74

2011

Link zum Volltext

Verfügbarkeit prüfen

Efficacy And Safety Of Sublingual 300IR 5-grass Pollen Tablets In Adult Patients With Grass-pollen Rhinoconjunctivitis In United States

Journal of allergy and clinical immunology, 2011-02, Vol.127 (2), p.AB74-AB74

2011

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and Safety of House Dust Mites Allergen Extracts Tablets in Adults With Allergic Rhinitis Patients

Journal of allergy and clinical immunology, 2010-02, Vol.125 (2), p.AB122-AB122

2010

Link zum Volltext

Verfügbarkeit prüfen

Efficacy Endpoints Of A 5 Grass Pollen Sublingual Tablets In Adults And Children

Journal of allergy and clinical immunology, 2010-02, Vol.125 (2), p.AB35-AB35

2010

Link zum Volltext

Verfügbarkeit prüfen

Absence de néosensibilisation lors de l’immunothérapie sublinguale (ITSL)

Revue française d'allergologie (2009), 2013-04, Vol.53 (3), p.387-388

2013

Link zum Volltext

Verfügbarkeit prüfen

6MO Translational relevance of the combined treatment PARP inhibitors and AsiDNA in homologous recombination proficient tumors

Annals of oncology, 2022-03, Vol.33, p.S4

2022

Link zum Volltext

Verfügbarkeit prüfen

Une induction de cellules dendritiques régulatrices en l’absence de lymphocytes T CD4+ régulateurs, corrèle avec l’efficacité clinique précoce de l’immunothérapie allergénique

Revue française d'allergologie (2009), 2013-04, Vol.53 (3), p.359-360

2013

Link zum Volltext

Verfügbarkeit prüfen

À la recherche de biomarqueurs de l’immunothérapie allergénique sublinguale

Revue française d'allergologie (2009), 2012-04, Vol.52 (3), p.274-275

2012

Link zum Volltext

Verfügbarkeit prüfen

Davos Declaration: Allergy as a global problem

Allergy (Copenhagen), 2012-02, Vol.67 (2), p.141-143

Ring, J.

2012

Link zum Volltext

Verfügbarkeit prüfen

Seasonal changes in nasal cytology in mite-allergic patients

Journal of inflammation research, 2014-01, Vol.7 (default), p.39-44

2014

Link zum Volltext

Verfügbarkeit prüfen

Allergen‐specific CD 4 + T cell responses in peripheral blood do not predict the early onset of clinical efficacy during grass pollen sublingual immunotherapy

Clinical and experimental allergy, 2012-12, Vol.42 (12), p.1745-1755

2012

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 210

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(160)
Mit Volltextzugriff
(166)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Development and evaluation of a sublingual tablet based on recombinant Bet v 1 in birch pollen‐allergic patients

Allergen Immunotherapy (AIT): a prototype of Precision Medicine

The average Adjusted Symptom Score, a new primary efficacy end-point for specific allergen immunotherapy trials

House dust mite sublingual immunotherapy is safe in patients with mild‐to‐moderate, persistent asthma: a clinical trial

House dust mite sublingual immunotherapy is safe and appears to be effective in moderate, persistent asthma

In allergic rhinitis, work, classroom and activity impairments are weakly related to other outcome measures

Absence of IgE neosensitization in house dust mite allergic patients following sublingual immunotherapy

The minimally important difference in the Rhinoconjunctivitis Total Symptom Score in grass‐pollen‐induced allergic rhinoconjunctivitis

Comments on: "allergen immunotherapy as a drug: the new deal of grass allergen tablets from clinical trials to current practice"

Allergen-specific CD4+ T cell responses in peripheral blood do not predict the early onset of clinical efficacy during grass pollen sublingual immunotherapy

Changes in basophil activation during grass‐pollen sublingual immunotherapy do not correlate with clinical efficacy

Post-treatment, Long-term Clinical Efficacy Of A 300 IR Sublingual Tablet of 5-grass Pollen Allergen Extract In Adults With Grass Pollen-induced Allergic Rhinoconjunctivitis

Sustained Efficacy and Safety Of a Pre-coseasonal 300IR 5-grass Pollen SLIT Tablet Over 3 Pollen Seasons In Adult SAR

Consistency Of Clinical Results Throughout Short-term And Long-term Studies With Sublingual 300IR 5-grass Pollen Tablets

Post-treatment Efficacy Of House Dust Mites (HDM) Sublingual Immunotherapy (SLIT) Tablets In Adult Patients

Efficacy And Safety Of Sublingual 300IR 5-grass Pollen Tablets In Adult Patients With Grass-pollen Rhinoconjunctivitis In United States

Efficacy and Safety of House Dust Mites Allergen Extracts Tablets in Adults With Allergic Rhinitis Patients

Efficacy Endpoints Of A 5 Grass Pollen Sublingual Tablets In Adults And Children

Absence de néosensibilisation lors de l’immunothérapie sublinguale (ITSL)

6MO Translational relevance of the combined treatment PARP inhibitors and AsiDNA in homologous recombination proficient tumors

Une induction de cellules dendritiques régulatrices en l’absence de lymphocytes T CD4+ régulateurs, corrèle avec l’efficacité clinique précoce de l’immunothérapie allergénique

À la recherche de biomarqueurs de l’immunothérapie allergénique sublinguale

Davos Declaration: Allergy as a global problem

Seasonal changes in nasal cytology in mite-allergic patients

Allergen‐specific CD 4 + T cell responses in peripheral blood do not predict the early onset of clinical efficacy during grass pollen sublingual immunotherapy

Suchergebnisse filtern